SJD Barcelona Children's Hospital

What SJD Barcelona Children's Hospital does

SJD Barcelona Children's Hospital is a private non-profit mother-and-child tertiary hospital founded in 1867 and operated by the Hospitaller Order of St. John of God, headquartered on a single campus in Esplugues de Llobregat, Barcelona. The institution provides specialised paediatric and maternal-foetal medicine, obstetrics, and gynaecology across more than a dozen clinical services (neurosurgery, refractory epilepsy, cardiology and cardiac surgery, oncology, neurology, orthopaedics, ophthalmology, rare diseases, neuroimmunology, diagnostic imaging, ambulatory surgery, laboratory services, and a paediatric A&E) supported by 600+ specialists. In 2024 it handled 327,283 outpatient consultations, 176,334 emergencies, 17,287 surgical procedures, and 3,559 births. Its core operational model is direct in-person and virtual care delivery to patients sourced from Spain's public system, private payers, and an international referral flow coordinated through dedicated International Patient Services and an online second-opinion channel.

The hospital differentiates through a portfolio of strategic centres and platforms rather than a single product: the SJD Pediatric Cancer Center Barcelona (PCCB, 400+ new patients/year), the BCNatal maternal-foetal consortium with Hospital Clínic, the Congenital Cardiopathy Centre Barcelona, the Únicas Network for rare diseases with the Spanish Ministry of Health and la Caixa Foundation, and an Advanced Therapies Platform that holds European MIA accreditation to manufacture CAR-T and gene therapies for other centres. Technology assets include paediatric-exclusive 3 Tesla MRI scanners, the DoseWatch radiation-monitoring software, an AVEIR-derived paediatric pacemaker co-developed with Abbott, and the TeLeo tele-education platform. Revenue is generated through direct healthcare services (public reimbursement, private/self-pay international patients, advanced-therapy manufacturing), research grants, and charitable programmes such as Cuida'm and the PCCB Charity Fund; specific revenue figures are not publicly disclosed. Governance sits within the Hospitaller Order of St. John of God, with day-to-day management recently transitioning to Miquel Pons i Serra.

Name

SJD Barcelona Children's Hospital

Legal name

Hospital Sant Joan de Déu Barcelona

Website

https://sjdhospitalbarcelona.org

Company type

Private

Founded year

1869

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

SJD Barcelona Children's Hospital is a non-profit tertiary mother-and-child hospital in Barcelona, Spain, providing specialised paediatric, maternal-foetal, and gynaecological care across 20+ specialties, with 600+ specialists and 327,000+ outpatient consultations annually.

Ownership category

akta.pro rank

Product category

Paediatric Hospital Services

NAICS

General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Children’s Hospitals & Pediatric Health Systems (HLAFAJAG)

akta.pro secondary industries

Maternal-Fetal Medicine (High-Risk Pregnancy) Centers (HLAFAJAB), Oncology & Cancer Specialty Hospitals (HLAFAHAC), Women’s & Children’s Surgical Care Centers (HLAFAJAM)

Keywords

• Paediatric hospital services
• Maternal-fetal medicine
• Paediatric oncology treatment
• Rare disease care
• Paediatric surgery

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Direct Healthcare Services: The hospital generates revenue through providing direct medical and healthcare services to patients, including outpatient consultations, emergency care, surgical procedures, and specialized treatments. Services are provided to both public system patients and private/international patients.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

SJD Barcelona Children's Hospital provides specialised paediatric, maternal-foetal, obstetric, and gynaecological healthcare services delivered through in-person hospital care, telemedicine, and an online second opinion service. The hospital operates strategic centres (Pediatric Cancer Center Barcelona, BCNatal, Congenital Cardiopathy Centre Barcelona, Únicas Network) and an Advanced Therapies Platform for CAR-T and gene therapies. It also delivers professional training through the TeLeo tele-education platform and solidarity programmes such as Cuida'm for paediatric patients from developing countries.

Product overview

SJD Barcelona Children's Hospital is a mother and child centre offering specialised care in paediatrics, maternal-fetal medicine, obstetrics and gynaecology. The hospital operates a platform-plus-specialised-centres model, combining core medical services (Neurosurgery, Cardiology, Oncology, Neurology, Diagnostic Imaging, A&E, Ambulatory Surgery, Laboratory) with strategic centres: SJD Pediatric Cancer Center Barcelona (comprehensive cancer care for 400+ patients annually), BCNatal (maternal-foetal consortium with Hospital Clínic), Congenital Cardiopathy Centre Barcelona, and the Únicas Network (rare disease care). Advanced capabilities include the Advanced Therapies Platform (CAR-T manufacturing, MIA-accredited), and digital health through the Liquid Hospital project. The hospital also operates the TeLeo tele-education platform for paediatric oncology training in Latin America. Services include 327,283 outpatient consultations, 176,334 emergencies, 17,287 surgical procedures, and 3,559 births annually (2024 data), delivered by 600+ specialists.

Differentiator

Problem solved

Functional benefit

Brands

• SJD Pediatric Cancer Center Barcelona (PCCB): A comprehensive pediatric oncology center providing treatment for children and adolescents with cancer, integrating healthcare and research.
• BCNatal
• Únicas Network
• Advanced Therapies Platform
• TeLeo
• Cuida'm Program

Products and services

• SJD Pediatric Cancer Center Barcelona (PCCB) A comprehensive centre dedicated to the treatment of children and adolescents with cancer, integrating healthcare and research in one facility. Treats over 400 new cancer patients annually and serves as the European sponsor for Beat Childhood Cancer Consortium studies.
• BCNatal A consortium specialising in maternal-foetal medicine and neonatology, providing comprehensive care for women and babies from the mother's womb through a partnership between SJD Barcelona and Hospital Clínic Barcelona.
• Congenital Cardiopathy Centre Barcelona A partnership between SJD Hospital and Hospital Clinic Barcelona dedicated to comprehensive care for congenital heart diseases.
• Únicas Network A network to improve the diagnosis and care of patients with rare diseases, part of the Ministry of Health's Únicas Network enabling hospitals to share information for better rare disease care.
• Advanced Therapies Platform A platform providing advanced therapy manufacturing capabilities, including CAR-T production. SJD Barcelona was awarded European MIA accreditation to produce advanced therapies for other centres.
• TeLeo Platform Tele-education in Paediatric Oncology — a distance learning programme launched by SJD Barcelona providing free, high-quality online training for healthcare professionals in paediatric oncology, particularly in Latin America.
• Children's Accident and Emergency Department (A&E) Emergency care service for children using a validated triage system with five priority levels, prioritising care based on clinical urgency rather than arrival order.
• Ambulatory Surgery Unit (UCA) Surgical unit performing surgeries that do not require hospital admission, offering local, regional or general anaesthesia with leading inhalation anaesthesia techniques.
• Diagnostic Imaging Diagnostic imaging service performing over 5,000 CT scans and 6,000 MRIs annually. Uses 3 Tesla MRI scanners exclusively for paediatric patients, pioneering DoseWatch radiation monitoring software, and elastography ultrasound techniques.
• Laboratory Services Paediatric-focused blood collection and laboratory testing services with specialised staff trained to work with child patients, including fasting protocols adapted by age.
• International Patient Services Comprehensive services for international patients including treatment requests, online second medical opinions, and coordination for patients from around the world seeking specialised paediatric care.
• Paediatric and Women's Medical Services Comprehensive paediatric medical services including Neurosurgery, Refractory Epilepsy, Cardiology and Cardiac Surgery, Maternal-Foetal Medicine and Obstetrics, Oncology, Neurology, Orthopaedics and Traumatology, Ophthalmology, Rare Diseases, and Neuroimmunology.

Quantifiable outcome

• 90% overall survival rate at 3 years in high-risk neuroblastoma patients in first complete remission
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

13 partnerships are on record, tiered core and minor.

• la Caixa FoundationcoreStrategic or Co-development Partner · 4 June 2026Promoter of the Únicas Talks forum and supporter of the Únicas Network project for rare diseases care and diagnosis improvement in Spain.
• Spanish Federation of Rare Diseases (FEDER)coreStrategic or Co-development Partner · 4 June 2026Collaboration partner in Únicas Talks forums, working on strategies to improve care for rare diseases through coordination between all stakeholders.
• Generalitat de Catalunya (Galician Health Service)minorStrategic or Co-development Partner · 4 June 2026Collaborator in Únicas Talks Galicia 2026, contributing to discussions on rare disease strategies and government approaches.
• CIBERERminorStrategic or Co-development Partner · 4 June 2026Collaborator in Únicas Hackathon for rare and undiagnosed diseases, contributing to the over 50% diagnosis rate achieved.
• SLAOP (Latin American Society of Paediatric Oncology)coreStrategic or Co-development Partner · 2 June 2026Collaboration agreement recognizing TeLeo as the leading educational platform of choice in paediatric oncology. Formalises link with the most representative scientific society in Latin American paediatric oncology, opening opportunities for coordination and collaboration to enhance regional exchange and impact.
• Hospital Clínic Barcelona (BCNatal Consortium)coreStrategic or Co-development Partner · 28 May 2026BCNatal is a consortium specialising in maternal-foetal medicine and neonatology. Together, SJD and Clínic performed Europe's first operation on a foetus with gastroschisis, and operate the Congenital Cardiopathy Centre Barcelona for comprehensive congenital heart disease care.
• AbbottcoreTechnology or Integration · 4 March 2026Collaboration to develop the world's smallest pacemaker (2cm) for newborns. SJD professionals worked with Abbott engineers to design a synchronised pacemaker based on the AVEIR platform, specifically adapted for babies weighing as little as 2.1 kilograms.
• Columbus FoundationcoreStrategic or Co-development Partner · 26 February 2026Strategic partnership to promote the development of advanced therapies for ultra-rare diseases (SPG50, CLN7, CMT4J) and facilitate access for European paediatric patients. SJD Barcelona will care for and treat affected European paediatric patients while Columbus Foundation coordinates clinical development, regulatory strategy, and production with Elpida Therapeutics.
• Elpida TherapeuticscoreStrategic or Co-development Partner · 26 February 2026US-based non-profit company collaborating with Columbus Foundation and SJD Barcelona on clinical development, regulatory strategy, and production of advanced therapies for ultra-rare diseases (SPG50, CLN7, CMT4J).
• European Cancer Charities (ATTRACT 2025)coreStrategic or Co-development Partner · 26 February 2026Six European cancer charities (Anticancer Fund, Spanish Association Against Cancer, Fondation ARC, Kom op tegen Kanker, Rising Tide Foundation) joined forces to bolster international research for ARI-chALL clinical trial in paediatric leukaemia using CAR-T ARI-0001 therapy.
• Hospital Clinic BarcelonacoreStrategic or Co-development Partner · 26 February 2026Collaboration partner for CAR-T ARI-0001 therapy development. Dr Manel Juan at Hospital Clinic developed the CAR-T technology in collaboration with SJD Barcelona for paediatric applications. First CAR-T developed entirely in academia in Europe.
• Beat Childhood Cancer (BCC) ConsortiumcoreStrategic or Co-development Partner · 24 November 2025SJD Barcelona became the first facility not based in North America to join the BCC Research Consortium specialising in development of clinical trials on paediatric cancer. Acts as European sponsor for Consortium studies, facilitating collaboration with companies on new treatments. First trial: BCC18 for high-risk neuroblastoma.
• Trawick InternationalminorChannel Partner/ Reseller/ Distributor · 28 October 2025Partnership announced October 28, 2025, to provide Trawick International's insureds with access to specialized paediatric care and telemedicine services in Barcelona, Spain. Includes benefits such as reduced deductibles and free pre-travel medical evaluations, valid from November 1, 2025, to April 30, 2026.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Texas Children's Hospital: Major US pediatric hospital with extensive oncology, fetal, and rare disease programs and global patient services. Direct peer in scale, international patient programs, and complex pediatric specialty care.
• Hospital Necker-Enfants Malades (AP-HP): Leading French pediatric university hospital known for rare disease treatment, fetal surgery, and pediatric cardiology. Direct peer operating in maternal-fetal medicine, pediatric surgery, and complex disease specialization similar to SJD.
• Boston Children's Hospital: Largest pediatric research hospital in the US and global benchmark for complex pediatric care, oncology, and rare diseases. Directly comparable as a leading academic children's hospital with international patient services and advanced therapy programs where SJD Barcelona's Carme Fons received her training.
• Children's Hospital of Philadelphia (CHOP): Top-ranked US pediatric hospital and oncology center; member of the Beat Childhood Cancer Consortium with SJD. Direct peer for complex pediatric oncology, rare disease treatment, and clinical trial sponsorship comparable to SJD's PCCB.
• Alder Hey Children's Hospital: Leading UK pediatric hospital known for innovation, pediatric surgery, and research; comparable to SJD in scale and international patient focus.
• Great Ormond Street Hospital for Children (GOSH): Premier UK pediatric hospital specializing in complex and rare conditions, pediatric oncology, and fetal medicine. Direct peer operating in similar high-complexity pediatric space with international patient reach and research-driven care model.
• Bambino Gesù Pediatric Hospital: Vatican-owned European pediatric research hospital with strong focus on rare diseases, gene therapy, and international patient services. Direct comparable as a non-profit children's hospital with advanced therapies and global patient reach.

Broad incumbents

• Hospital Vall d'Hebron: Large Barcelona-based public hospital with pediatric, obstetric, and research capabilities serving the same Catalan region. Regional incumbent offering overlapping maternal-child services in SJD's home market.
• Hospital Universitario La Paz: Major Spanish public university hospital with substantial pediatric services, including high-complexity pediatric care and maternal-fetal medicine. Broad incumbent operating in the same Spanish healthcare ecosystem with overlapping pediatric specialty capabilities.

Regional players

• Royal Children's Hospital Melbourne: Leading Australian pediatric teaching hospital with strong research focus and complex pediatric care. Comparable in mission and capability set, but serves a different geography (Asia-Pacific) than SJD's European/Latin American focus.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/SJDbarcelona_es
• YouTubeyoutube.com/user/HSJDBCN
• Facebookfacebook.com/SJDHospitalBarcelona
• LinkedInlinkedin.com/company/sjdhospitalbarcelona
• Instagraminstagram.com/sjdhospitalbarcelona

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SJD Barcelona Children's Hospital